Experts Available to Discuss Breast Cancer and Early Detection.

ExpertSource:

TOPIC: Good Morning America's Robin Roberts' announcement that she was diagnosed with breast cancer has brought more attention to the importance of early detection. While breast cancer treatments have greatly improved over the past few decades, early detection is still crucial for recovery and survival, according to an article by ABC News. Some of the guidelines for screening from the American Cancer Society include: yearly mammograms for women aged 40 and older, yearly MRIs and mammograms for women who are considered to be high-risk, and that clinical breast exams be part of periodic health exams. The American Cancer Society also recommends breast self-exams for women starting in their 20s and that any changes be reported promptly to their physicians.

EXPERTS: ExpertSource can offer several highly qualified experts to comment on this story:

Ginger Meyers, the Director of Clinical Affairs for Power3 Medical Inc. in Houston, notes that in several news reports, Roberts' cancer was not immediately picked up on mammography and was only diagnosed after several invasive exams, including a biopsy. In fact, according to Meyers, Roberts' cancer may have developed several years ago, but has only now grown to the size where it can be detected. This reflects the critical need for earlier detection of breast cancer, which devastates the lives of hundreds of thousands of American women and their families every year.

Scientists at Power3, in conjunction with Mercy Hospital Women's Center, found that they could develop a test for breast cancer using blood serum. This test, called BC-SeraPro[TM], analyzes biomarkers, or specific proteins, that indicate the difference between normal breast tissue, a benign tumor, and a cancerous tumor.

Ginger Meyers can discuss:

* How early is early? What is the definition of early breast cancer and the role of biomarkers in early detection;

* How a simple blood test can help physicians diagnose cancer much earlier than current standards of detection;

* What would a blood test for breast cancer mean to women across the world and what impact it could have in breast cancer survival.

Meyers and her team at Power3 have spent the better part of two decades researching biomarkers and developing diagnostic tools. Meyers, a Registered Respiratory Therapist, has an Associates Degree in Allied Health Sciences and 26 years of clinical and healthcare management experience. She is articulate and knowledgeable in this area and can help your audience understand how early detection can save millions of lives.

PR Contact: Janet Vasquez
212-825-3210
[e-mail]

Dr. Randy Fink is a Fellow in American College of Obstetrics & Gynecology (ACOG), and has been active in the organization since 1997. Since moving to Miami in 2001, Dr. Fink has been a sub-investigator in several national women's health clinical trials involving contraception, sexuality, pregnancy concerns, and hormone replacement. Since 2003, he has been a peer reviewer for the Journal of Family Planning & Reproductive Health. A highly sought-after speaker, Dr. Fink has presented hundreds of programs on topics ranging from birth control to hormone replacement therapy.

PR Contact: Allison Ward Moore
941-758-4912
[e-mail]

ExpertSource cannot guarantee the immediate availability of these experts or their familiarity with this specific issue.

ExpertSource provides academic and industry experts to the media at no charge. Journalists are encouraged to submit queries to ExpertSource when seeking experts on specific subjects. An online registration form is available at http://www.businesswire.com/.